Advertisement

Topics

ChromaDex Reports Third Quarter 2017 Financial Results

11:05 EST 9 Nov 2017 | BioMedReports - Blog

Company Reports Third Quarter 2017 Revenue of $6.1 Million, Up 55% Compared to Last Year -
- Continued Progress on Building a Consumer Products Platform Around TRU NIAGEN-

IRVINE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE)

Read more...

Original Article: ChromaDex Reports Third Quarter 2017 Financial Results

NEXT ARTICLE

More From BioPortfolio on "ChromaDex Reports Third Quarter 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...